STAGE IIIB PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIIB PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIB PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in keeping High-Risk prostate cancer at bay
Disease control CompletedThis study looked at adding a drug called niraparib to the usual treatment (radiation plus hormone therapy) for men with high-risk prostate cancer. The goal was to see if the combination could lower the chance of the cancer growing or coming back. Twenty-two men took part, and re…
Matched conditions: STAGE IIIB PROSTATE CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New combo targets Hard-to-Treat cancers with gene mutations
Disease control CompletedThis early-phase study tested a new drug (AZD8186) combined with chemotherapy (docetaxel) in 23 adults with advanced solid tumors that have certain gene changes (PTEN or PIK3CB mutations). The main goal was to find the safest dose and understand side effects. Researchers hope thi…
Matched conditions: STAGE IIIB PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:58 UTC